Literature DB >> 19509114

Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.

Natalie M Moss1, Yueying Liu, Jeff J Johnson, Philip Debiase, Jonathan Jones, Laurie G Hudson, Hidayatullah G Munshi, M Sharon Stack.   

Abstract

The epidermal growth factor receptor (EGFR) is overexpressed in ovarian carcinomas and promotes cellular responses that contribute to ovarian cancer pathobiology. In addition to modulation of mitogenic and motogenic behavior, emerging data identify EGFR activation as a novel mechanism for rapid modification of the cell surface proteome. The transmembrane collagenase membrane type 1 matrix metalloproteinase (MT1-MMP, MMP-14) is a major contributor to pericelluar proteolysis in the ovarian carcinoma microenvironment and is subjected to extensive posttranslational regulation. In the present study, the contribution of EGFR activation to control of MT1-MMP cell surface dynamics was investigated. Unstimulated ovarian cancer cells display caveolar colocalization of EGFR and MT1-MMP, whereas EGFR activation prompts internalization via distinct endocytic pathways. EGF treatment results in phosphorylation of the MT1-MMP cytoplasmic tail, and cells expressing a tyrosine mutated form of MT1-MMP (MT1-MMP-Y(573)F) exhibit defective MT1-MMP internalization. As a result of sustained cell surface MT1-MMP activity, a phenotypic epithelial-mesenchymal transition is observed, characterized by enhanced migration and collagen invasion, whereas growth within three-dimensional collagen gels is inhibited. These data support an EGFR-dependent mechanism for regulation of the transition between invasive and expansive growth of ovarian carcinoma cells via modulation of MT1-MMP cell surface dynamics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509114      PMCID: PMC2843416          DOI: 10.1158/1541-7786.MCR-08-0571

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  104 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking.

Authors:  Peter Thomsen; Kirstine Roepstorff; Martin Stahlhut; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

Review 3.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.

Authors:  S M Ellerbroek; Y I Wu; C M Overall; M S Stack
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

Review 5.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

6.  Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status.

Authors:  Y N Kim; G J Wiepz; A G Guadarrama; P J Bertics
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

7.  Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.

Authors:  D P Wang; I Konishi; M Koshiyama; Y Nanbu; T Iwai; H Nonogaki; T Mori; S Fujii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

Authors:  A Berchuck; G C Rodriguez; A Kamel; R K Dodge; J T Soper; D L Clarke-Pearson; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

9.  Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.

Authors:  Stéphanie Langlois; Carine Nyalendo; Geneviève Di Tomasso; Lyne Labrecque; Christian Roghi; Gillian Murphy; Denis Gingras; Richard Béliveau
Journal:  Mol Cancer Res       Date:  2007-05-31       Impact factor: 5.852

10.  Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2.

Authors:  Farrah Kheradmand; Kirtee Rishi; Zena Werb
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  19 in total

Review 1.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

Review 2.  Three-dimensional in vitro tumor models for cancer research and drug evaluation.

Authors:  Xian Xu; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biotechnol Adv       Date:  2014-08-10       Impact factor: 14.227

3.  Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.

Authors:  Jing Yang; William C Kasberg; Angela Celo; Zhong Liang; Kristal Quispe; M Sharon Stack
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

4.  The transcription factor SPDEF suppresses prostate tumor metastasis.

Authors:  Joshua J Steffan; Sweaty Koul; Randall B Meacham; Hari K Koul
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

5.  Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes.

Authors:  Surabhi Dangi-Garimella; Amanda J Redig; Mario A Shields; Mohammed A Siddiqui; Hidayatullah G Munshi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

6.  FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex.

Authors:  Nami Sugiyama; Markku Varjosalo; Pipsa Meller; Jouko Lohi; Kui Ming Chan; Zhongjun Zhou; Kari Alitalo; Jussi Taipale; Jorma Keski-Oja; Kaisa Lehti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

7.  Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.

Authors:  Natalie M Moss; Maria V Barbolina; Yueying Liu; Limin Sun; Hidayatullah G Munshi; M Sharon Stack
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 8.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

Review 9.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

Review 10.  Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Authors:  Jin-Hong Chang; Yu-Hui Huang; Christy M Cunningham; Kyu-Yeon Han; Michael Chang; Motoharu Seiki; Zhongjun Zhou; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2015-12-02       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.